<html>
<head>PUBMED IDs for RTKN</head>
<body bgcolor='#C5F0F2'><h1>RTKN</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9073523/'>Localization of the rhotekin gene RTKN on the physical maps of mouse chromosome 6 and human chromosome 2p13 and exclusion as a candidate for mnd2 and LGMD2B.</a> March 15  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10873388/'>Molecular cloning, expression characterization, and mapping of a novel putative inhibitor of rho GTPase activity, RTKN, to D2S145-D2S286.</a> June 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316142/'>Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma.</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316122/'>Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15480428/'>Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis.</a> October 14  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15504364/'>Identification and characterization of a lymphocytic Rho-GTPase effector: rhotekin-2.</a> October 27  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15599595/'>Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients.</a> December 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/26124677/'>RTKN2 Induces NF-KappaB Dependent Resistance to Intrinsic Apoptosis in HEK Cells and Regulates BCL-2 Genes in Human CD4(+) Lymphocytes.</a> January 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/26124677/'>RTKN2 Induces NF-KappaB Dependent Resistance to Intrinsic Apoptosis in HEK Cells and Regulates BCL-2 Genes in Human CD4(+) Lymphocytes.</a> January 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19360360/'>miR-145 inhibits breast cancer cell growth through RTKN.</a> August 4  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23028356/'>Functional variants in NFKBIE and RTKN2 involved in activation of the NF-κB pathway are associated with rheumatoid arthritis in Japanese.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24880483/'>miR-1246 releases RTKN2-dependent resistance to UVB-induced apoptosis in HaCaT cells.</a> October 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26349972/'>Effect of RTKN on progression and metastasis of colon cancer in vitro.</a> June 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26686412/'>Transcriptome profiling of human FoxP3+ regulatory T cells.</a> November 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26935528/'>Inhibition of rhotekin exhibits antitumor effects in lung cancer cells.</a> December 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27082503/'>Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.</a> April 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27081789/'>Knockdown of Rhotekin 2 expression suppresses proliferation and invasion and induces apoptosis in hepatocellular carcinoma cells.</a> April 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27498032/'>Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer.</a> May 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27922690/'>MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.</a> December 7  2016<br></body></html>
